CASCIO, Sandra
 Distribuzione geografica
Continente #
NA - Nord America 3.526
EU - Europa 2.710
AS - Asia 513
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 4
AF - Africa 3
OC - Oceania 1
Totale 6.764
Nazione #
US - Stati Uniti d'America 3.522
FI - Finlandia 738
DE - Germania 568
IT - Italia 468
UA - Ucraina 411
CN - Cina 402
GB - Regno Unito 125
IE - Irlanda 118
SE - Svezia 106
RU - Federazione Russa 61
BE - Belgio 48
KR - Corea 27
IR - Iran 19
FR - Francia 18
IN - India 14
RO - Romania 12
PK - Pakistan 11
EU - Europa 7
NL - Olanda 7
AT - Austria 6
CH - Svizzera 6
ID - Indonesia 5
TR - Turchia 5
GR - Grecia 4
HK - Hong Kong 4
CA - Canada 3
CZ - Repubblica Ceca 3
LB - Libano 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
BG - Bulgaria 2
EG - Egitto 2
HU - Ungheria 2
KH - Cambogia 2
MY - Malesia 2
PL - Polonia 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BY - Bielorussia 1
CR - Costa Rica 1
ES - Italia 1
GE - Georgia 1
IL - Israele 1
JP - Giappone 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
SG - Singapore 1
UY - Uruguay 1
UZ - Uzbekistan 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 6.764
Città #
Fairfield 376
Ann Arbor 331
Ashburn 307
Woodbridge 288
Chandler 269
Wilmington 244
Houston 243
Jacksonville 228
Seattle 135
Dublin 118
Cambridge 114
Palermo 106
Nanjing 96
Medford 91
New York 66
Princeton 59
Boardman 52
Des Moines 52
Tulsa 52
Altamura 50
Brussels 48
Lawrence 35
Shenyang 31
Venice 31
Ludwigshafen am Rhein 30
Nanchang 30
Dearborn 28
Jinan 28
San Mateo 27
Seongnam 27
Beijing 26
San Diego 25
Milan 23
Jiaxing 22
Changsha 19
Hebei 18
Helsinki 18
Ningbo 18
Verona 17
Tianjin 15
Auburn Hills 13
San Paolo di Civitate 12
Kunming 11
Lancaster 11
Tehran 11
Hangzhou 10
Kumar 10
Taizhou 10
Zhengzhou 10
Falls Church 9
Guangzhou 9
Saint Petersburg 9
Los Angeles 8
Taiyuan 8
London 7
Melfi 7
Phoenix 7
Lanzhou 6
Moscow 6
Redwood City 6
Fuzhou 5
Haikou 5
Izmir 5
Atlanta 4
Kilburn 4
Montauk 4
Central District 3
Den Haag 3
Edinburgh 3
Hefei 3
Ludwigshafen 3
Munich 3
Norwalk 3
Bremen 2
Busto Arsizio 2
Changchun 2
Falkenstein 2
Hamden 2
Kiev 2
Naples 2
Orange 2
Ottawa 2
Phnom Penh 2
Prescot 2
Pune 2
Rome 2
San Francisco 2
Stockholm 2
Washington 2
Absecon 1
Abu Dhabi 1
Almaty 1
Asunción 1
Athens 1
Augusta 1
Aversa 1
Baku 1
Bangkok 1
Belgrade 1
Bern 1
Totale 4.064
Nome #
4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily). 260
TP53 and p16INK4A, but not H-KI-Ras, are involved in tumorigenesis and progression of pleomorphic adenomas. 198
Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features 188
Founder mutations in BRCA1 and BRCA2 genes 188
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma 174
BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses. 161
Pharmacogenomics in colorectal carcinomas: Future perspectives in personalized therapy 158
Laser Pressure Catapulting (LPC): Optimization LPC-System and Genotyping of Colorectal Carcinomas 146
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. 144
Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 143
A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer. 143
Ductal lavage: a way of carefully tracing the breast-secreting duct 142
Q356R and S1512I are BRCA1 variants that may be associated with breast cancer in a Sicilian family. 138
Analysis of Ki-Ras mutations in stage I rectal carcinomas and respective regional lymph nodes. 138
BRCA 1/2 GENES MUTATIONAL SCREENING IN SICILIAN BREAST AND/OR OVARIAN CANCER FAMILIES 136
TP53, H-K-RAS, P16INK4A GENE MOLECULAR ANALYSIS IN SALIVARY GLAND TUMORS 136
miR-20b Modulates VEGF Expression by Targeting HIF-1a and STAT3 in MCF-7 Breast Cancer Cells 136
BRCA1/BRCA2 genes mutational screening in Sicilian breast and/or ovarian cancer families. 135
Molecular analysis of TP53, Ki-Ras and P16 methylation status in tissue and plasma of subjects affected by gastrointestinal cancer (GIC) 131
Analysis of TP53, Ki-Ras and P16INK4A promoter methylation as potential prognostic factors in patients with colorectal cancer 130
Insulin-dependent leptin expression in breast cancer cells. 130
Genotype analysis of colorectal carcinomas through laser pressare catapulting (LPC) 128
GENOTYPE ANALYSIS OF COLORECTAL CARCINOMAS THROUGH LASER PRESSURE CATAPULTING (LPC) 126
Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli 126
BRCA1 germline mutations in Sicilian breast and/or ovarian cancer families and their implications for genetic counselling. 126
TP53, Ki-Ras and P16INK4A gene molecular analysis in salivary gland tumors. 123
A missense mutation associated to early onset breast cancer in a sicilian woman. 121
Aplotype analysis in four sicilian families with 5083del19bp-BRCA1. 118
Mutational analysis of BRCA1 gene in sicilian patients at risk for inherited breast and/or ovarian cancer: experience of reference centre for the biomolecular characterization of neoplasms and genetic screening of hereditary tumors. 117
Molecular analysis of TP53, Ki-Ras and P16 methylation status in tissue and plasma of subjects affected by gastrointestinal cancer 117
Detection and clinical relevance of free-circulating tumor DNA in blood of patients with colorectal cancer 113
TP53, h-k-ras,p16ink4a gene molecular analysis in salivary gland tumors 110
A study of a new germline mutation in BRCA1 gene in two Sicilian families: a founder mutation? 107
BRCA 1/2 VARIANTS OF UNCERTAIN CLINICAL SIGNIFICANCE IN PATIENTS WITH FAMILIAL AND HEREDITARY BREAST/OVARIAN CANCER 105
BRCA1 missense variants of uncertain clinical significance in unaffected and breast/ovarian cancer of the Sicilian population. 105
Analysis of Ki-ras mutations in stage I rectal carcinomas and respective regional lymphonodes 99
Expression level of the mammaglobin (MGB1) gene in BC:possibile index of BC progression 99
A.Mutational analysis of BRCA1 in sicilian patients at risk for inherited of reference center for the biomolecular characterizaztion of neoplasm and genetic screening of hereditary tumors 98
DNA-aneuploidy and high SPF and specific p53 mutations are independent prognostic factors in colorectal cancer (CRC). 95
The estrogen receptor alpha:insulin receptor substrate 1 complex in breast cancer: structure-function relationships 91
Mechanism of leptin expression in breast cancer cells: role of hypoxia-inducible factor-1alpha. 89
Detection of free-circulating tumor DNA in plasma of patients with gastrointestinal cancer. 89
The prognostic role of TP53 mutations in advanced laryngeal squamous cell carcinoma (LSCC). 88
Detection and clinical relevance of free-circulating tumor DNA in blood of patients with colorectal cancer. Proceeding of ICACT Fifteenth International Congress on Anticancer Treatment February 9th 12th 2004, Paris accepted for oral presentation 87
TP53 mutations are not prognostic independent indicators in bladder cancer. 86
Insulin-like growth factor 1 differentially regulates estrogen receptor-dependent transcription at estrogen response element and AP-1 sites in breast cancer cells. 86
Mutational analysis of BRCA1 gene in sicilian patient at risk for inherited breast and/or ovarian cancer: experience of reference center the biomolecular characterization of neoplasm and genetic screening of hereditary tumors. 85
TP53 Mutation in exon 5 and S-Phase Fraction but not Mutations in Ras gene family and DNA-ploidy are Indipendent prognostic indicators in Laryngeal Squamous Cell Carcinoma 83
TP53 in exon 5 and s-Phase fraction but not mutations in Ras gen family and DNA-ploidy are indipendent indicators in laryngeal squamous cell carcinoma 78
BRCA1/2 variants of uncertain clinical significance in patients with famlial and hereditary breast/ovarian cancer 78
DNA-Aneuploidy, High SPF and Specific P53 Mutations are Indipendent Prognostic Factors in Colorectal Cancer (CRC) 77
Detection and clinical relevance of free circulating tumor DNA in blood of patients with gastrointestinal cancer 77
DNA aneuploidy, high SPF and specific p53 mutations are independent prognostic factors in colorectale cancer (CRC) 73
TP53 mutation are not prognostic indipendent indicators in bladder cancer 70
HPV-INFECTION IN ORAL SQUAMOUS CELL CARCINOMA IN RELATION WITH S-PHASE KINASE-INTERACTING PROTEIN 2 AND P27KIP1 PROTEIN EXPRESSION 70
TP53 mutations are not prognostic indipendent indicators in bladder cancer 69
Use of saliva as a biological medium in non invasive screening for oral cancer 63
Expression of the obesity hormone leptin and its receptor correlates with hypoxia-inducible factor-1alpha in human colorectal cancer. 49
TRANSKETOLASE-LIKE 1 EXPRESSION IN PAPILLARY THYROID CARCINOMAS SMALLER THAN 1.5 CM 45
null 3
null 3
PRC2 allosteric modulation an alternative strategy in drug discovery for the epigenetic diseases 1
Totale 6.828
Categoria #
all - tutte 18.443
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.443


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019200 0 0 0 0 0 0 0 0 0 0 95 105
2019/20201.464 163 50 103 106 155 154 167 82 138 81 196 69
2020/2021763 31 112 37 77 65 18 73 27 117 36 91 79
2021/2022680 32 161 12 35 30 14 47 25 80 92 36 116
2022/2023842 110 152 11 80 126 103 46 56 107 7 39 5
2023/2024401 22 59 37 21 23 120 43 67 1 8 0 0
Totale 6.828